Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

27

Revenue 2017

Gilenya

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gilenya was produced by Novartis.

FDA approves Novartis' next-gen MS drug Mayzent

FDA approves Novartis' next-gen MS drug Mayzent

It is part of a new class of S1P-receptor modulators that are safer and more effective than the first generation drugs, such as Novartis’ top-earner Gilenya, which brought in

Drug launches to watch in 2019

Drug launches to watch in 2019 Its success is vital, as Novartis’ $3.2bn franchise for Gilenya is facing increased competition.

Novartis forges AI alliance with Oxford University

Novartis forges AI alliance with Oxford University Novartis will be contributing clinical and MRI data from more than 35, 000 MS patients gleaned from its clinical development programmes for drugs like Gilenya (fingolimod).

Novartis: pipeline will generate 60 filings in three years

Novartis: pipeline will generate 60 filings in three years Mayzent is a follow-up to Novartis’ blockbuster MS therapy Gilenya (fingolimod), which brought in $2.5bn in the first nine months of the year and is facing the threat of

Novartis files for approval of MS drug in EU, US

Novartis files for approval of MS drug in EU, US Siponimod (BAF312) – which is a follow-up to Novartis’ established MS therapy Gilenya (fingolimod) – is the first and so far only drug to have demonstrated it can delay the progression of ... That’s the same mechanism as $3bn-a-year product

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics